Andor Glaudemans
prof. dr.
I am a nuclear medicine specialist and always trying to implement innovative diagnostic and therapeutic methods in imaging. My main research interests involve infectious and inflammatory diseases, tumor-immunology, and development of new-targeted diagnostic tools for PET imaging. The latter focus is carried out in close collaboration with our radiochemists. Within the lymphoma research Groningen team we have a close collaboration with the department of hematology. The research is focused on finding new methods for diagnosis and therapy evaluation in several types of lymphomas. We have a special interest in post-transplant lymphatic disorders (PTLD). Furthermore, we are developing and evaluating several fields of radionuclide therapy, so called theranostics.
Treatment and Follow-up of Vascular Graft and Endograft Infection: Delphi Consensus Document
Published in: Clinical Microbiology and Infection
Access to document
10.1016/j.cmi.2025.07.020
document
SCOPE: Vascular graft or endograft infection (VGEI) is a severe complication requiring a multidisciplinary approach combining surgery and antimicrobial therapy. This study aimed to develop expert consensus on the management and follow-up of VGEI, with a focus on antimicrobial strategies. METHODS: A modified Delphi method was conducted to reach consensus on key aspects of VGEI care, including antimicrobial treatment, surgical management, and follow-up. An expert panel representing infectious diseases, vascular and cardiothoracic surgery, microbiology, and nuclear medicine participated in four rounds of surveys. Ten general and 35 specific...
Ilse J E Kouijzer, Marta Hernández-Meneses, Erik H J G Aarntzen, Jonas Ahl, Larry M Baddour, Daniel C DeSimone, Emanuele Durante Mangoni, Nuria Fernández-Hidalgo, Guillaume S C Geuzebroek, Efthymia Giannitsioti, Andor W J M Glaudemans, Lars Husmann, Marco Merli, Carlos A Mestres, Flaminia Olearo, Matthaios Papadimitriou-Olivgeris, Nis Pedersen Jørgensen, Andrés Perissinotti, Annibale Raglio, Zoran RancicAkshatha Ravindra, Benedikt Reutersberg, Leonardo Francesco Rezzonico, Marco Ripa, Petar Risteski, Alessandro Russo, Ben Saleem, Karl Sörelius, Dolores Sousa, Pierre Tattevin, Marjan Wouthuyzen-Bakker, Thomas R Wyss, Xavier Yugueros, Alexander Zimmermann, Barbara Hasse
Comparative analysis of FES-PET/CT and FDG-PET/CT in patients with ER-positive metastatic invasive lobular breast cancer
Published in: European Journal of Cancer
Access to document
10.1016/j.ejca.2025.115792
document
BACKGROUND: Detection of metastatic invasive lobular carcinoma (mILC) with standard imaging is challenging. 2-[18F]Fluoro-2-deoxyglucose (FDG) PET/CT is commonly used in the work-up of metastatic breast cancer (MBC), but may be suboptimal for mILC. 16α-[18F]Fluoro-17β-estradiol (FES) PET/CT measures estrogen receptor (ER) expression, which is generally high in mILC. To assess whether FES-PET/CT outperforms FDG-PET/CT, we compared the detection rate of both scans to identify mILC, in patients who were enrolled in the prospective IMPACT-MBC study. METHODS: Patients with newly diagnosed ER-positive mILC underwent baseline FDG-PET/CT, FES-PET/CT, diagnostic computed tomography...
IMPACT-Metastatic Breast Consortium, Jasmine Moustaquim, Gabriëlle E van Wonderen, Jasper J L van Geel, Michel van Kruchten, Erik F J de Vries, Agnes Jager, Evelien Kuip, Marcel P M Stokkel, Andor W J M Glaudemans, Adrienne H Brouwers, Geke A P Hospers, C Willemien Menke-van der Houven van Oordt, Bert van der Vegt, Elisabeth G E de Vries, Carolina P Schröder
First-In-Human PET Imaging of Two Novel Antibody Fragments in Patients with Solid Tumors – a Phase 0 Nuclear Imaging Basket Trial (VARTUTRACE)
N.C. van Dijk, A.F.S. Verhaar, Y.F. Janssen, M. Brom, T. Gustavsson, S. Dagil, S. Choudhary, E.E. Vidal-Calvo, D. Waagmeester, D.J. Vugts, T.G. Theander, H.H. Boersma, A. Salanti, A.W.J.M. Glaudemans, G.M. van Dam
Impact of Ultrahigh Sensitivity and Continuous Bed Motion on Performance Characteristics of Biograph Vision Quadra PET/CT
Published in: Journal of Nuclear Medicine
Access to document
10.2967/jnumed.125.270078
document
Continuous bed motion (CBM) for long-axial-field-of-view PET/CT enables swift total-body examination of patients. However, the sensitivity profile along the axial field of view (AFOV) varies significantly, and its effect on image quality when combined with CBM remains unexplored. This study assesses the effects of ultrahigh sensitivity (UHS) and CBM on recovery coefficients (RCs) and spatial resolution (SR). Methods: Phantom measurements, performed in static bed and CBM acquisition with different bed speeds (3.5, 7, 14, and 30 mm/s), were reconstructed for both high-sensitivity (HS) and UHS modes, and their...
How can children benefit from total-body PET?
Published in: British journal of radiology
Access to document
10.1093/bjr/tqaf242
document
The introduction of long axial field-of-view (LAFOV) PET/CT scanners marks a major advancement in paediatric nuclear medicine. These systems provide greatly enhanced sensitivity, enabling superior image quality with reduced radiopharmaceutical doses and substantially shorter scan times. This is particularly advantageous in children, who are more radiosensitive and often struggle with prolonged procedures that may require sedation. LAFOV PET/CT allows whole-body imaging in a single bed position, reducing motion artefacts, improving patient comfort, and lessening procedural anxiety. Such benefits align with the ALARA (As Low As Reasonably Achievable) principle,...
Paul J H van Snick, Sasha O V Ivashchenko, Joyce van Sluis, Limme B de Langen, Georgie C van den Oever, Mostafa Roya, Andor W J M Glaudemans, Riemer H J A Slart